The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients

Objective: To determine the effects of Tualang Honey (TH) on bone mineral density (BMD) as assessed by dual energy X-ray absorptiometry (DEXA) scan when used as an adjunct to anastrazole among postmenopausal breast cancer patients. Methodology: Patients (n=33) were recruited from the Oncology Clini...

Full description

Bibliographic Details
Main Author: Hassan, Nor Hasnina Mohd
Format: Thesis
Language:English
Published: 2016
Subjects:
Online Access:http://eprints.usm.my/43294/
http://eprints.usm.my/43294/1/Dr.%20Nor%20Hasnina%20Mohd%20Hassan-24%20pages.pdf
_version_ 1848879783549599744
author Hassan, Nor Hasnina Mohd
author_facet Hassan, Nor Hasnina Mohd
author_sort Hassan, Nor Hasnina Mohd
building USM Institutional Repository
collection Online Access
description Objective: To determine the effects of Tualang Honey (TH) on bone mineral density (BMD) as assessed by dual energy X-ray absorptiometry (DEXA) scan when used as an adjunct to anastrazole among postmenopausal breast cancer patients. Methodology: Patients (n=33) were recruited from the Oncology Clinic, Hospital USM, Kelantan, Malaysia. The inclusion criteria included postmenopausal women with breast cancer stages I, II, or III, oestrogen receptor (ER) positive and/or progesterone receptor (PgR) positive. The patients were randomized to receive either anastrozole (1 mg) alone or anastrazole (1 mg) and TH (20 g) intervention group. Bone DEXA scan was conducted twice, at baseline (during the first visit) and six months later. Results: The T scores were significantly decreased when compared to the baseline for both femoral (−0.40 vs −0.50, p = 0.013) and the lumbar spine (−1.60 vs –1.70, p = 0.034), following six months of anastrozole alone treatment. On the other hand, there was no significant difference between the baseline and the T scores following six months of treatment for both femoral (0.35 vs. 0.50, p = 0.286) and the lumbar spine (−1.05 vs –0.95, p = 0.074) for the intervention group indicating that TH can ameliorate bone loss as a resultof anastrazole use. Administration of anastrozole significantly reduced the median femoral BMD by 2.23% and median lumbar spinal BMD by 2.84% after six months. However, in the intervention group, there was no significant change in term of both BMD and T score when compared to the baseline following six months which again indicate the potential of TH in ameliorating bone loss. Conclusions: TH has the potential to be used as an adjunct to prevent bone loss among postmenopausal breast cancer women treated with anastrozole
first_indexed 2025-11-15T17:52:43Z
format Thesis
id usm-43294
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T17:52:43Z
publishDate 2016
recordtype eprints
repository_type Digital Repository
spelling usm-432942019-04-12T05:25:28Z http://eprints.usm.my/43294/ The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients Hassan, Nor Hasnina Mohd R Medicine Objective: To determine the effects of Tualang Honey (TH) on bone mineral density (BMD) as assessed by dual energy X-ray absorptiometry (DEXA) scan when used as an adjunct to anastrazole among postmenopausal breast cancer patients. Methodology: Patients (n=33) were recruited from the Oncology Clinic, Hospital USM, Kelantan, Malaysia. The inclusion criteria included postmenopausal women with breast cancer stages I, II, or III, oestrogen receptor (ER) positive and/or progesterone receptor (PgR) positive. The patients were randomized to receive either anastrozole (1 mg) alone or anastrazole (1 mg) and TH (20 g) intervention group. Bone DEXA scan was conducted twice, at baseline (during the first visit) and six months later. Results: The T scores were significantly decreased when compared to the baseline for both femoral (−0.40 vs −0.50, p = 0.013) and the lumbar spine (−1.60 vs –1.70, p = 0.034), following six months of anastrozole alone treatment. On the other hand, there was no significant difference between the baseline and the T scores following six months of treatment for both femoral (0.35 vs. 0.50, p = 0.286) and the lumbar spine (−1.05 vs –0.95, p = 0.074) for the intervention group indicating that TH can ameliorate bone loss as a resultof anastrazole use. Administration of anastrozole significantly reduced the median femoral BMD by 2.23% and median lumbar spinal BMD by 2.84% after six months. However, in the intervention group, there was no significant change in term of both BMD and T score when compared to the baseline following six months which again indicate the potential of TH in ameliorating bone loss. Conclusions: TH has the potential to be used as an adjunct to prevent bone loss among postmenopausal breast cancer women treated with anastrozole 2016 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/43294/1/Dr.%20Nor%20Hasnina%20Mohd%20Hassan-24%20pages.pdf Hassan, Nor Hasnina Mohd (2016) The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients. Masters thesis, Universiti Sains Malaysia.
spellingShingle R Medicine
Hassan, Nor Hasnina Mohd
The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title_full The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title_fullStr The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title_full_unstemmed The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title_short The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
title_sort effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
topic R Medicine
url http://eprints.usm.my/43294/
http://eprints.usm.my/43294/1/Dr.%20Nor%20Hasnina%20Mohd%20Hassan-24%20pages.pdf